medigraphic.com

2012, Número 2

Rev Mex Med Fis Rehab 2012; 24 (2)


Prevalencia de neuropatía autonómica cardiovascular en pacientes con diabetes mellitus tipo 2 y estandarización en población mexicana por medio de la variabilidad de la frecuencia cardiaca

Gutiérrez FÁJ, Montes CML, Jiménez OJH

Idioma: Español
Referencias bibliográficas: 61
Paginas: 45-55
Archivo PDF: 395.48 Kb.


RESUMEN

Objetivo: Estandarizar los parámetros de normalidad de la variabilidad de la frecuencia cardiaca en 100 sujetos sanos y determinar la frecuencia de la neuropatía autonómica cardiovascular en pacientes con diabetes mellitus tipo 2 en ambos sexos. Material y métodos: Estudio transversal analítico en dos etapas: Primera etapa: estandarización de la prueba de variabilidad de la frecuencia cardiaca, captando 100 sujetos sanos entre las edades de 40 y 85 años de edad mediante 3 pruebas a la metodología de Ewing. Segunda etapa: 41 pacientes con diabetes mellitus tipo 2 en edades de 40 y 85 años. Se utilizó un aparato de electromiografía mediante la utilización del programa HRV con el método de análisis de tiempo, al ejecutar tres pruebas: 6 respiraciones profundas, bipedestación, maniobra de Valsalva. Usamos estadística analítica estimando la t de Student para muestras independientes y el coeficiente de Pearson para establecer la correlación. Resultados: Se captaron 100 sujetos sanos para obtener valores de referencia. Se evaluaron 41 sujetos con diagnóstico de DM tipo 2. En los pacientes con diabetes mellitus obtuvimos que más del 60% presentaron neuropatía autonómica cardiovascular: 41.4% con disfunción autonómica y 19.4% con neuropatía definida. Conclusiones: Se logró estandarizar la variabilidad de la frecuencia cardiaca en población mexicana, teniendo como parámetro de referencia para determinar la frecuencia de neuropatía autonómica cardiovascular siendo mayor a la establecida en la literatura internacional.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Expert Committee on the Diagnosis and Classification of Diabetes Diabetes Care 2006; 29 (Suppl. 1): S43-S48.

  2. Jermendy G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetologica 2003; 40: S370.

  3. Curtis MB, O’Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc 2002.

  4. Perkins, Bruce A, Bril Vera. Early vascular risk factor modification in type 1 diabetes. The New England Journal of Medicine 2005; 352(4): 408-409.

  5. Freeman R. Autonomic peripheral neuropathy. The Lancet 2005; 365, 9466, 1259.

  6. Spallone V, Menzinger G. Diagnosis of cardiovascular autonomic neuropathy in diabetes. Diabetes 1997; 46.

  7. Vinik IA, Maser ER, Mitchell DB. Roy freeman diabetic autonomic neuropathy. Diabetes Care 2003; 26(5): 1553.

  8. Quirantes HA, López GL, Curbelo SV, Montano LJA, Machado LP, Quirantes MA. La calidad de vida del paciente diabético. Rev Cubana Med Gen Integ 2000; 16(1): 50-6.

  9. Vinik IA, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-397.

  10. Ziegler D, Sohr GHC, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy. Diabetes Care 2004; 27(9): 2178.

  11. Ziegler D, Gries FA, Muhlen H, Rathmann W, Spuler M, Lessmann F et al. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab 1993; 19: 143-151.

  12. Maguire A, Craighead A, Craig M et al. Autonomic nerve testing predicts the development of complications: a 12-year follow up study. Diabetes Care 2007; 30: 1.

  13. Vinik A, Erbas T. Recognizing and treating diabetic autonomic neuropathy Cleveland. Clinic Journal of Medicine 2001; 68(11).

  14. Gerritsen J, Dekker MJ, TenVoorde JB; Kostense JP et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease. The Hoorn Study. Diabetes Care 2001; 24: 10.

  15. Moran A, Palmas W, Field L, Bhattarai J et al. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 2004; 27(4): 972.

  16. Hauerslev FC, Vestbo E, Froland A, Gjessing HJ et al. Autonomic neuropathy in non diabetic offspring of type 2 diabetic subjects is associated with urinary albumin excretion rate and 24-h ambulatory blood pressure. Diabetes 2001; 50: 3.

  17. Bruna AJ, Navarro X. Neuropatía autonómica en la diabetes mellitus. Rev Neurol 2005; 40(2): 102-110.

  18. Cameron EN, Cotter AM. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997; 46(S2): 31-37.

  19. Erewster WJ. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. TINS 1994; 7(8): 321-24.

  20. Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 2004; 146: 477-492.

  21. Pittenger G, Vinik A. Nerve growth factor and diabetic neuropathy. Exp Diabetic Res 2003; 4(4): 271-85.

  22. Hilsted J. Pathophysiology in diabetic autonomic neuropathy. Cardiovascular, hormonal, and metabolic studies. Diabetes 1982; 31: 730.

  23. Leinninger GM, Vincent AM, Feldman EL. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 2004; 9(1): 26-53.

  24. Pfeifer M, Feldman E. Diabetic autonomic neuropathy, 2004. In: The diabetes mellitus. Manual 6th Edition. Ed. New York, McGraw Hill, 2004; 351.

  25. Vita G, Princi P, Messina C. Multivariate analysis of cardiovascular reflexes applied to the diagnosis of autonomic neuropathy. Journal of Neurology 1991; 238(5).

  26. Kaye JM, Corrall RJ, Lightman SL. A new test for autonomic cardiovascular and neuroendocrine responses in diabetes mellitus: evidence for early vagal dysfunction. Diabetologia 2005; 48: 180-186.

  27. Ziegler D. Diabetic autonomic neuropathy cardiac sympathetic “dysinnervation” QT interval prolongation, and mortality. Clin Auton Res 2002; 12: 349-352.

  28. Colberg SR, Swain D, Vinik IA. Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. Diabetes Care 2003; 26: 986-990.

  29. Parati G. Cardiovascular variability analysis. An insight into the pathophysiology of cardiovascular disease and the impact of treatment. With caution. Clin Auton Res 2002; 12: 4-8.

  30. Langer A, Freeman M, Josse R, Steiner G et al. Am J Cardiol 1991; 67: 1073-1078.

  31. Raelene EM, Braxton DM, Aaron IV et al. The association between cardiovascular autonomic neuropathy and mortality in Individual with diabetes a meta analysis. Diabetes Care 2003; 26(6): 1895.

  32. Lahrmann H, Magnifico F, Haensch A et al Autonomic nervous system laboratories: a European survey. European Journal of Neurology 2005; 12: 375-379.

  33. Boulton M, Arezzo CV et al. A statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962.

  34. Chessa M, Butera G, Lanza GA et al. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children Herz Urban & Vogel. 2002; 785.

  35. American Diabetes Association. Report and recommendations of the San Antonio Conference on the diabetic neuropathy. Muscle and Nerve 1988; 661-667.

  36. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-918.

  37. Sztajzel J. Heart rate variability: a noninvasive electrocardiographic Method to measure the autonomic nervous system. Swiss Med Wkly 2004; 134: 514-522.

  38. Risk M, Bril V, Broadbridge C et al. Heart Rate variability measurement in diabetic neuropathy: review of methods diabetes technology & therapeutics. 2001; 3(1): 63-76.

  39. Radespiel-Tröger M, Rauh R, Mahlke C et al. Agreement of two different methods for measurement of heart rate variability. Clin Auton Res 2003; 13: 99-102.

  40. Ryder REJ, Hardisty CA. Which battery of cardiovascular autonomic function tests? Diabetologia 1990; 33: 177-179.

  41. Frattola A, Parati G, Gamba P et al. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia 1997; 40: 1470-1475.

  42. Lishner M, Akselrod S, Avi VM, Oz O, Divon M, Ravid M. Spectral analysis of heart rate fluctuations. A noninvasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus. J Auton Nerv Syst 1987; 19: 119-125.

  43. Gert van Dijk J. Heart rate variability testing, or listening to a conversation in a foreign language. Clin Auton Res 2003; 13: 304-305.

  44. Makimattila S, Schlenzka A, Mantysaari M, Bergholm R et al. Predictors of abnormal cardiovascular autonomic function measured by frequency Domain Analysis of heart variability and conventional test in patients with type 1 diabetes. Diabetes Care 2000; 23: 11-1686.

  45. Pagani M, Malfatto G, Pierini S et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 1988; 23: 143-153.

  46. García J, Serrano A, del Castillo S et al. Predictores de muerte súbita en la enfermedad coronaria. Rev Esp Cardiol 2000; 53: 440-462.

  47. Van Ravenswaaij-Arts, Conny MA, Louis AK et al. Heart rate variability review annals of internal medicine. 1993; 118(6): 436-447.

  48. Low v. Clinical autonomic disorders. Evaluation and Management 2a Edition Editorial Lippincott-Raven 1997. In: Vinik A, Park T, Stansberry K, Pittenger G. Diabetic neuropathies: Diabetologia 2000; 43: 957-973.

  49. Meter D. Drummond the effect of pain on changes in heart rate during the Valsalva manoeuvre. Clin Auton Res 2003; 13: 316-320.

  50. Claus D, Meudt O, Rozeik C et al. Prospective investigation of autonomic cardiac neuropathy in diabetes mellitus. Clin Auton Res 2002; 12: 373-378.

  51. Mateika HJ, DeMeersman ER, Kim J. Effects of lung volume and chemoreceptor activity on blood pressure and R-R interval during the Valsalva maneuver. Clin Auton Res 2002; 12: 24-34.

  52. Vita G, Princi P, Messina C. Multivariate analysis of cardiovascular reflexes applied to the diagnosis of autonomic neuropathy. Journal of Neurology 1991; 238.

  53. Eckberg DL, Harkins SW, Frisch JM, Musgrave GE, Gadner DF. Baroreflex control of plasma norepinephrine and heart rate period in healthy subjects and diabetic patients. J Clin Invest 1986; 78: 366-374.

  54. Gulli G, Fattor B, Marchesi M. Cross-spectral analysis of cardiovascular variables in supine diabetic patients. Clin Auton Res 2005; 15: 92-98.

  55. Hilstead J, Parving HH, Christensen NJ, Benn J, Galbo H. Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 1981; 68: 1427-1434.

  56. Zhang Y, Critchley LA, Tam YH, Tomlinson B. Short-term postural reflexes in diabetic patients with autonomic dysfunction. Diabetologia 2004; 47: 304-311.

  57. Pfeifer MA, Peterson H. Cardiovascular autonomic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte AD, eds. Diabetic neuropathy. Philadelphia: WB Saunders, 1987: 122-33.

  58. Jacob G, Costa F, Biaggioni I. Spectrum of autonomic cardiovascular neuropathy in diabetes. Diabetes Care 2003; 26(7): 2174.

  59. Krivickas L. Electrodiagnosis in neuromuscular disorders. Saunders Company 2003: 287-310.

  60. Huggett RJ, Scott EM, Gilbey SG, Bannister J. Disparity of autonomic control in type 2 diabetes mellitus. Diabetologia 2005; 48: 172-179.

  61. Tamošiūnaitė M, Urbonavičienė G, Vainoras A et al. Influence of deep breathing on heart rate variability in patients with ischemic heart disease elektronika ir elektrotechnika. 2005: 3(59).




2020     |     www.medigraphic.com